Patienter med før- eksisterende leverfunktionssvigt inklusive kronisk aktiv hepatitis har en højere risiko for leverfunktionsabnormaliteter under antiretroviral kombinationsbehandling og bør monitoreres ifølge standard i praksis.
Patients with pre-existing liver dysfunction including chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice.